Cytotoxicity of a natural anthraquinone (Aloin) against human breast cancer cell lines with and without ErbB-2: topoisomerase IIalpha coamplification

Cancer Biol Ther. 2006 Jan;5(1):97-103. doi: 10.4161/cbt.5.1.2347. Epub 2006 Jan 22.

Abstract

In the present study the cytotoxic activity of aloin, a natural anthracycline from Aloe plant, is reported against two human breast cancer cell lines; without (MCF-7) and with (SKBR-3) erbB-2-topoIIalpha coamplification. MCF-7cell line was shown to be more sensitive to aloin than SKBR-3 demonstrated by MTT and clonogenic assays, from which IC50 and 50% ICF values are reported to be 60 microg/ml, respectively, in the former cell line and as high as 150 and 80 microg/ml, respectively, in the latter, which are still far below the maximum tolerated dose of the compound. The effect of aloin is suggested to be brought about by more than one mechanism depending on the dose level and tumor phenotype. This was demonstrated by flow cytometric analysis, fluorescence microscopy and western blot analysis, which revealed that aloin at higher concentrations caused a reduction in the proportion of cells undergoing mitosis by induction of apoptosis, inhibition of topo II alpha protein expression and downregulation of cyclin B1 protein expression in MCF-7 cell line, whereas erbB-2 protein expression was not affected. Topo IIalpha protein expression was mildly downregulated in SKBR-3 cell line at higher concentrations only.

Publication types

  • Comparative Study

MeSH terms

  • Antigens, Neoplasm / analysis
  • Antigens, Neoplasm / genetics*
  • Antigens, Neoplasm / metabolism
  • Apoptosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics
  • Cell Line, Tumor
  • Cyclin B / genetics
  • Cyclin B / metabolism
  • DNA Topoisomerases, Type II / analysis
  • DNA Topoisomerases, Type II / genetics*
  • DNA Topoisomerases, Type II / metabolism
  • DNA-Binding Proteins / analysis
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Down-Regulation
  • Drug Resistance, Neoplasm / genetics*
  • Emodin / analogs & derivatives*
  • Emodin / therapeutic use
  • Flow Cytometry
  • Gene Amplification*
  • Humans
  • Mitosis / drug effects
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / genetics*
  • Receptor, ErbB-2 / metabolism

Substances

  • Antigens, Neoplasm
  • Cyclin B
  • DNA-Binding Proteins
  • Receptor, ErbB-2
  • DNA Topoisomerases, Type II
  • Emodin
  • alloin